US FDA tightens regulations for use of erythopoiesis-stimulating agents

被引：0

作者：

不详

机构：

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：483 / 483

页数：1

共 50 条

Santini, Valeria .

[32] Erythropoiesis-Stimulating Agents in Anemia: Use and Misuse [J].

Dharmarajan, T. S. ;

Widjaja, David .

[33] US FDA warns public about new butyrolactone-related agents [J].

[34] Paediatric SSRI use falls after US FDA warning [J].

[35] US FDA restricts use of opioid products for coughs/colds [J].

[36] UK MCA and US FDA concerned over use of kavain [J].

[37] US FDA halts use of triclosan in health care antiseptics [J].

Hogue, Cheryl .

[38] US FDA limits Imodium packaging to foster safe use [J].

[39] US FDA advises against use of Zicam cold products [J].

[40] US FDA advises cautious use of fluconazole during pregnancy [J].